Universal Health Services, Inc. (UHS) fair value analysis
S&P 500 · Updated 2026-10-19
UHS price how computed
Forward Fair Value verdict
UndervaluedUHS is trading at more than a 25% discount to estimated fair value.
Based on TickrTrends' weekly Forward Fair Value model.
- Last price
- $177.35
- Sector
- Healthcare
- 12-month range
- $141.17–$244.18
- Market cap
- $10.9B
- From 52-week high
- -27.4%
- Shares outstanding
- 61.5M
- Rank in Healthcare by discount to fair value
- #22 of 108
Last price is our 2026-10-19 weekly price; the chart runs through 2026-10-16.
Universal Health Services, Inc. is a healthcare company that operates a network of acute care hospitals and behavioral health facilities. The company provides inpatient and outpatient services across the United States and Puerto Rico.
UHS currently ranks #22 of 108 Healthcare stocks by discount to fair value. It has screened as Undervalued for 14 consecutive weekly runs.
Fundamentals (4 quarters) how computed
- Market cap
- $10.9B
- P/E (trailing)
- 8x
- Revenue (TTM)
- $18.1B
- Net margin
- 8.4%
- EPS (TTM)
- $23.17
- Gross margin
- 90.9%
- Debt / equity
- 0.70
- Revenue growth (3-yr avg)
- 10.1%
- Shares outstanding
- 61.5M
Derived indicators how computed
- Quality grade
- C
- Margin trend
- Stable
- 52-week position
- The lower-middle quarter of its range
- DCF cross-check
- Undervalued
Technicals how computed
- RSI (14-day)
- 57 · neutral
- 50-day average
- $175.36
- 200-day average
- $178.50
- Moving-average state
- 50-day below 200-day (death cross state); price between the averages
Dividends how computed
- Paid, last 12 months
- $0.80 per share (4 payments)
- Yield on last price
- 0.45%
- Consecutive years of increases
- 0 (no streak on complete calendar years)
- Last ex-dividend date
- 2026-09-01
- Last payment date
- 2026-09-15
Earnings how computed
- Next earnings report
- 2026-10-27 (post-market)
- Last 8 quarters vs consensus
- 7 beat, 0 missed
- Quarter by quarter
- 2026-06 ▲ beat (+5.7%)
2026-03 ▲ beat (+2.9%)
2025-12 ▬ met (0.0%)
2025-09 ▲ beat (+14.9%)
2025-06 ▲ beat (+7.9%)
2025-03 ▲ beat (+11.0%)
2024-12 ▲ beat (+17.8%)
2024-09 ▲ beat (+0.3%)
Analyst consensus how computed
This is not TickrTrends' verdict.
- Analyst ratings
- 7 buy · 12 hold · 1 sell (20 analysts)
- Consensus lean
- Hold-leaning
- Consensus price target
- $196
- Target vs last price
- +10.5%
What our data shows for UHS
- Our model validated 17 trailing price-to-earnings windows for UHS, built from quarterly earnings records.
- Shares are trading in the middle of their 12-month price range of $141.17–$244.18.
- The 14-day relative strength index sits at a neutral 57.
The exact numbers are one step away
- The precise Forward Fair Value dollar figure for UHS
- Exact discount / premium to today's price
- The normalized historical P/E behind the estimate, and how many quarters support it
- Forward EPS input and fiscal-year basis
- Screeners and rankings across the full S&P 500 and Nasdaq universes
Forward Fair Value applies a conservatively normalized historical price-to-earnings multiple to the consensus earnings estimate for the next full fiscal year; how TickrTrends computes it.
Recent UHS news
TickrTrends' derived news-sentiment signal for UHS is currently leaning positive, computed from recent coverage.
- Universal Health: Bears Have Taken It Too Far - 134% Upside (NYSE:UHS) (seekingalpha.com, 2026-10-20)
TickrTrends take: Universal Health Services trades at a valuation that TickrTrends currently assesses as undervalued within the Healthcare sector, which aligns with analyst commentary suggesting the market has moved too bearishly on the stock. A valuation-focused reader should monitor whether UHS can demonstrate operational improvements that would justify closing the gap between current market pricing and the upside potential identified in recent analysis. The company's ability to execute on margin expansion or revenue growth initiatives will be key to determining whether the undervaluation thesis proves accurate or represents a value trap. - DIMENSIONAL FUND ADVISORS LP Boosts Universal Health Services Inc (UHS) Stake -- Shares Look 22% Undervalued on GF Value (gurufocus.com, 2026-10-15)
TickrTrends take: Dimensional Fund Advisors LP's decision to increase its position in Universal Health Services suggests institutional confidence in the company's value proposition at current prices. TickrTrends' assessment that UHS shares are undervalued aligns with the analyst perspective cited in the news, indicating that multiple value-focused observers see a disconnect between the stock's current market price and its intrinsic worth. For valuation-conscious investors monitoring the Healthcare sector, this convergence of institutional buying activity and undervaluation signals warrants attention to whether the market will eventually close the valuation gap. - Universal Health Services, Inc. Announces Date and Time Change for Third Quarter 2026 Earnings Release and Conference Call (manilatimes.net, 2026-10-09)
TickrTrends take: Universal Health Services operates in the Healthcare sector where earnings announcements represent key catalysts for valuation reassessment. With TickrTrends currently assessing UHS as undervalued, the timing and content of the third quarter 2026 earnings release will be critical for investors to evaluate whether the current valuation discount reflects genuine operational challenges or represents an opportunity based on underlying business performance. Valuation-focused readers should monitor the earnings results and management commentary for evidence that supports or challenges the current undervalued classification.
More UHS news
- Universal Health Services Inc at Robert W Baird Global Healthcare Conference Transcript (gurufocus.com, 2026-09-15)
- Universal Health Services, Inc. (UHS) Presents at 2026 Global Healthcare Conference Transcript (seekingalpha.com, 2026-09-15)
What people are saying
Follow the UHS conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-10-19 — UHS momentum indicator declined this week, shifting from a C grade to no rating, suggesting a loss of upward price movement. Despite this weakening momentum, the stock maintains an undervalued position according to TickrTrends' derived indicators, indicating that valuation metrics continue to suggest the share price may be trading below intrinsic value relative to fundamentals in the healthcare sector.
- 2026-10-12 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-11 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-10 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-06 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-28 — UHS momentum indicator has shifted to a C rating this week, moving from no previous reading. The stock remains classified as undervalued according to TickrTrends' valuation assessment within the Healthcare sector.
- 2026-09-21 — Universal Health Services Inc (UHS) moved to an undervalued status this week as TickrTrends' DCF cross-check band shifted from fairly valued to undervalued. The company operates in the healthcare sector and now presents a different valuation picture than it did in the prior week based on the updated analysis.
- 2026-09-17 — No material change this week: the verdict, bands and grades all held steady.
Frequently asked questions
Is UHS stock undervalued?
Based on TickrTrends' Forward Fair Value model (updated 2026-10-19), UHS is trading at more than a 25% discount to estimated fair value and screens as undervalued. The exact fair value and discount are available to subscribers.
What is UHS's TickrTrends verdict?
UHS's current verdict is Undervalued, refreshed with every weekly Forward Fair Value run.
How does UHS compare to other Healthcare stocks?
UHS ranks #22 of 108 Healthcare stocks in TickrTrends' coverage by discount to fair value.
Is UHS overbought or oversold?
UHS's 14-day RSI is in neutral territory - neither overbought nor oversold.
Does UHS pay a dividend?
Yes. UHS paid $0.80 per share over the last twelve months (4 payments), a 0.45% yield on TickrTrends' last price. The last ex-dividend date was 2026-09-01.
When does UHS report earnings next?
UHS's next earnings report is scheduled for 2026-10-27 (post-market), per the published earnings calendar.
Does UHS usually beat earnings estimates?
Over its last 8 reported quarters UHS beat the consensus estimate 7 times and missed 0 times, by TickrTrends' comparison of reported and estimated EPS.
What do analysts say about UHS?
Of 20 analysts covering UHS, 7 rate it a buy, 12 a hold and 1 a sell - hold-leaning, with a consensus price target of $196 (+10.5% versus TickrTrends' last price). This is the analyst consensus, not TickrTrends' Forward Fair Value verdict.
More in Healthcare
Head-to-head comparisons
UHS vs ABT · UHS vs AMPH · UHS vs GEHC · UHS vs IDXX · UHS vs INCY